Importer of Controlled Substances Application: NSI Lab Solutions, Inc., 37257-37260 [2024-09811]

Download as PDF 37257 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices Controlled substance Drug code Phenazocine ........................................................................................................................................................................ Thiafentanil .......................................................................................................................................................................... Piminodine ........................................................................................................................................................................... Racemethorphan ................................................................................................................................................................. Racemorphan ...................................................................................................................................................................... Alfentanil .............................................................................................................................................................................. Remifentanil ......................................................................................................................................................................... Sufentanil ............................................................................................................................................................................. Carfentanil ........................................................................................................................................................................... Tapentadol ........................................................................................................................................................................... Bezitramide .......................................................................................................................................................................... Fentanyl ............................................................................................................................................................................... Moramide-intermediate ........................................................................................................................................................ The company plans to import analytical reference standards for distribution to its customers for research and analytics purposes. Placement of these drug codes onto the company’s registration does not translate into automatic approval of subsequent permit applications to import controlled substances. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized in 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Marsha Ikner, Acting Deputy Assistant Administrator. [FR Doc. 2024–09803 Filed 5–3–24; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1361] Importer of Controlled Substances Application: NSI Lab Solutions, Inc. Drug Enforcement Administration, Justice. AGENCY: ACTION: Notice of application. NSI Lab Solutions, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before June 5, 2024. Such persons may also file a written request for a hearing on the application on or before June 5, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking SUMMARY: In accordance with 21 CFR 1301.34(a), this is notice that on March 22, 2024, NSI Lab Solutions, Inc., 7212 ACC Boulevard, Raleigh, North Carolina 27617, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: ddrumheller on DSK120RN23PROD with NOTICES1 Drug code 3-Fluoro-N-methylcathinone (3–FMC) ................................................................................................................................. Cathinone ............................................................................................................................................................................ Methcathinone ..................................................................................................................................................................... 4-Fluoro-N-methylcathinone (4–FMC) ................................................................................................................................. Pentedrone (a-methylaminovalerophenone) ....................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) ........................................................................................................................ 4-Methyl-N-ethylcathinone (4–MEC) ................................................................................................................................... Naphyrone ........................................................................................................................................................................... 3-methylmethcathinone (2-(methylamino)-1-(3- methylphenyl)propan-1-one) .................................................................... N-Ethylamphetamine ........................................................................................................................................................... Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2- amine) ......................................................................................... N,N-Dimethylamphetamine .................................................................................................................................................. Fenethylline ......................................................................................................................................................................... Aminorex .............................................................................................................................................................................. 4-Methylaminorex (cis isomer) ............................................................................................................................................ 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4- methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5- (4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine). 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00098 Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II Number, your comment has been successfully submitted and there is no need to resubmit the same comment. All requests for a hearing must be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. Controlled substance VerDate Sep<11>2014 9715 9729 9730 9732 9733 9737 9739 9740 9743 9780 9800 9801 9802 Schedule E:\FR\FM\06MYN1.SGM 06MYN1 1233 1235 1237 1238 1246 1248 1249 1258 1259 1475 1478 1480 1503 1585 1590 1595 Schedule I I I I I I I I I I I I I I I I 37258 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code Gamma Hydroxybutyric Acid ............................................................................................................................................... Methaqualone ...................................................................................................................................................................... Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine .................................... Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ............................... Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ...................................... Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .............................. Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1- methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ................... JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...................................................................................................... SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .................................................... ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ................. 5-Fluoro-UR–144 and XLR11 ([1-(5-Fluoro-pentyl)1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl)methanone) ................ AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ......................... (1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3- tetramethylcyclopropyl)methanone .................................................................. JWH–019 (1-Hexyl-3-(1-naphthoyl) indole) ......................................................................................................................... MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .......................... FUB–AMB, MMB–FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) AB–PINACA (N-(1-amino-3-methyl- .................................................................................................................................... 1-oxobutan-2-yl)-1-pentyl-1H-indazole-)3-carboxamide ...................................................................................................... THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3- ....................................................................................................................... yl](naphthalen-1-yl)methanone) ........................................................................................................................................... 5F–AB–PINACA (N-(1-amino-3methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) .......................... ADB–BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan2-yl)-1-butyl-1H-indazole-3-carb .................................................. AB–CHMINACA (N-(1-amino-3-methyl-1- ........................................................................................................................... oxobutan-2-yl)-1-(cyclohexylmethyl)- ................................................................................................................................... 1H-indazole-3-carboxamide) ............................................................................................................................................... MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ............ 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .................................................. ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................... Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)- 3,3-dimethylbutanoate ................................................................ MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3dimethylbutanoate). 4F–MDMB–BINACA (4F–MDMB–BUTINACA or methyl 2- (1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3dimethylbutanoate). MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ............ APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ................................................................ JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...................................................................................................... MDMB–4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4- en-1-yl)-1H-indazole-3-carboxamido)butanoate) ....................... SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ....................................................................... JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) .................................................................................. JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ......................................................................................................... UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .................................................................... JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ........................................................................................................................... JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) .............................................................................................. AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ........................................................................................................... JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) .......................................................................................................... NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ............................................................. PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..................................................................................................... 5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ................................................................................ Alpha-ethyltryptamine .......................................................................................................................................................... Ibogaine ............................................................................................................................................................................... Lysergic acid diethylamide .................................................................................................................................................. Marihuana extract ................................................................................................................................................................ Marihuana ............................................................................................................................................................................ Tetrahydrocannabinols ........................................................................................................................................................ Mescaline ............................................................................................................................................................................. JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) .......................................................................................................... 3,4-Methylenedioxyamphetamine ........................................................................................................................................ 3,4-Methylenedioxymethamphetamine ................................................................................................................................ Alpha-methyltryptamine ....................................................................................................................................................... Bufotenine ............................................................................................................................................................................ Diethyltryptamine ................................................................................................................................................................. Dimethyltryptamine .............................................................................................................................................................. Psilocybin ............................................................................................................................................................................. Psilocyn ............................................................................................................................................................................... 4-chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP) ................................................................................................ N-Benzylpiperazine .............................................................................................................................................................. 2C–I (2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) ............................................................................................................ 2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ........................................................................................................ 2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) ................................................................................................. MDPV (3,4-Methylenedioxypyrovalerone) ........................................................................................................................... 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ........................................................ Methylone (3,4-Methylenedioxy-N-methylcathinone) .......................................................................................................... Butylone ............................................................................................................................................................................... Pentylone ............................................................................................................................................................................. VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00099 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1 Schedule 2010 2565 2780 2785 2786 2788 2789 6250 7008 7010 7011 7012 7014 7019 7020 7021 7023 I I I I I I I I I I I I I I I I I 7024 I 7025 7027 7031 I I I 7032 7033 7035 7041 7042 I I I I I 7043 I 7044 7048 7081 7090 7104 7118 7122 7144 7173 7200 7201 7203 7221 7222 7225 7249 7260 7315 7350 7360 7370 7381 7398 7400 7405 7432 7433 7434 7435 7437 7438 7443 7493 7518 7521 7524 7535 7537 7540 7541 7542 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 37259 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices ddrumheller on DSK120RN23PROD with NOTICES1 Controlled substance Drug code N-Ethylpentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) ........................................................ a-PVP (alpha-pyrrolidinopentiophenone) ............................................................................................................................ a-PBP (alpha-pyrrolidinobutiophenone) .............................................................................................................................. Ethylone ............................................................................................................................................................................... PV8, alpha-Pyrrolidinoheptaphenone .................................................................................................................................. Eutylone ............................................................................................................................................................................... a-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1- one) .............................................................................................. AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ....................................................................................................... Acetyldihydrocodeine ........................................................................................................................................................... Codeine-N-oxide .................................................................................................................................................................. Desomorphine ..................................................................................................................................................................... Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)- 1,3-dihydro-2H-benzo[d]imidazol-2-one) .................................... Heroin .................................................................................................................................................................................. Morphine-N-oxide ................................................................................................................................................................ Myrophine ............................................................................................................................................................................ Nicomorphine ....................................................................................................................................................................... Normorphine ........................................................................................................................................................................ Pholcodine ........................................................................................................................................................................... Thebacon ............................................................................................................................................................................. U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .................................................................. AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ...................................................................... MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ...................................................................................................... Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine) ................................ Dimethylthiambutene ........................................................................................................................................................... Dipipanone ........................................................................................................................................................................... Etonitazene .......................................................................................................................................................................... Ketobemidone ...................................................................................................................................................................... Tilidine ................................................................................................................................................................................. Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1Hbenzimidazol-1-yl)-N,N-diethylethan-1 ...................................................... Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro1H-benzimidazol-1-yl)ethan-1-amine) ............................................. Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5- nitro-1H-benzimidazol-1-yl)ethan-1-amine) ................................... N-pyrrolidino etonitazene; etonitazepyne (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)- 1H-benzimidazole) ..... Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1-yl)ethan-1-amine) ......................................... Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)- 1H-benzimidazol-1-yl)ethan-1-amine) ......................................... Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1Hbenzimidazol-1-yl)-N,N-diethyleth ..................................................... Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) ..................................................................................... Para-Fluorofentanyl ............................................................................................................................................................. 3-Methylfentanyl .................................................................................................................................................................. Alpha-Methylfentanyl ........................................................................................................................................................... Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ................................................................................... Butyryl Fentanyl ................................................................................................................................................................... Para-fluorobutyryl fentanyl ................................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ............................................. 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide ............................................................................................. Para-chloroisobutyryl fentanyl ............................................................................................................................................. Isobutyryl fentanyl ................................................................................................................................................................ Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ................................................................. Thiofentanyl ......................................................................................................................................................................... Beta-hydroxythiofentanyl ..................................................................................................................................................... Ocfentanil ............................................................................................................................................................................. Valeryl fentanyl .................................................................................................................................................................... Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-Nphenylbenzamide; also known as benzoyl fentanyl) .............................. beta′-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3- diphenylpropanamide; also known as b′-phenyl fentanyl; 3phenylpropanoyl fentanyl). N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) ............................................................................. Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-Nphenylbut-2-enam ........................................................................... Cyclopropyl Fentanyl ........................................................................................................................................................... Cyclopentyl fentanyl ............................................................................................................................................................ Fentanyl related-compounds as defined in 21 CFR 1308.11(h) ......................................................................................... 2′-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2’-fluoro 2- fluorofentanyl). Amphetamine ....................................................................................................................................................................... Methamphetamine ............................................................................................................................................................... ANPP (4-Anilino-N-phenethyl-4-piperidine) ......................................................................................................................... Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) ....................................................................................................... 1-Piperidinocyclohexanecarbonitrile .................................................................................................................................... Cocaine ................................................................................................................................................................................ Codeine ............................................................................................................................................................................... Dihydrocodeine .................................................................................................................................................................... Oxycodone ........................................................................................................................................................................... Hydromorphone ................................................................................................................................................................... Diphenoxylate ...................................................................................................................................................................... Ecgonine .............................................................................................................................................................................. Ethylmorphine ...................................................................................................................................................................... VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00100 Fmt 4703 Sfmt 4703 E:\FR\FM\06MYN1.SGM 06MYN1 Schedule 7543 7545 7546 7547 7548 7549 7551 7694 9051 9053 9055 9098 9200 9307 9308 9312 9313 9314 9315 9547 9551 9560 9614 9619 9622 9624 9628 9750 9751 9756 9757 9758 9759 9764 9765 9811 9812 9813 9814 9821 9822 9823 9824 9825 9826 9827 9834 9835 9836 9838 9840 9841 9842 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 9843 9844 9845 9847 9850 9855 I I I I I I 1100 1105 8333 8366 8603 9041 9050 9120 9143 9150 9170 9180 9190 II II II II II II II II II II II II II 37260 Federal Register / Vol. 89, No. 88 / Monday, May 6, 2024 / Notices Controlled substance Drug code Hydrocodone ....................................................................................................................................................................... Levorphanol ......................................................................................................................................................................... Isomethadone ...................................................................................................................................................................... Meperidine ........................................................................................................................................................................... Meperidine-intermediate-A .................................................................................................................................................. Meperidine intermediate-B .................................................................................................................................................. Meperidine intermediate-C .................................................................................................................................................. Methadone ........................................................................................................................................................................... Methadone intermediate ...................................................................................................................................................... Dextropropoxyphene, bulk (non-dosage forms) .................................................................................................................. Morphine .............................................................................................................................................................................. Oripavine ............................................................................................................................................................................. Thebaine .............................................................................................................................................................................. Opium, raw .......................................................................................................................................................................... Opium extracts .................................................................................................................................................................... Opium fluid extract .............................................................................................................................................................. Opium tincture ..................................................................................................................................................................... Opium, powdered ................................................................................................................................................................ Opium, granulated ............................................................................................................................................................... Oxymorphone ...................................................................................................................................................................... Noroxymorphone ................................................................................................................................................................. Alfentanil .............................................................................................................................................................................. Remifentanil ......................................................................................................................................................................... Sufentanil ............................................................................................................................................................................. Carfentanil ........................................................................................................................................................................... Tapentadol ........................................................................................................................................................................... Bezitramide .......................................................................................................................................................................... Fentanyl ............................................................................................................................................................................... The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 6, 2024, concerning an application for an Importer of Controlled Substances. The document request removal of Dimethyltrytamine. SUMMARY: SUPPLEMENTARY INFORMATION: In the Federal Register on March 6, 2024, in FR Doc No: 89 FR 16029, FR No. 2024–04753, on pages 16029–16030 (2 pages), in the first column, remove the controlled substance Dimethltrytamine from the list to read as follows: Controlled substance Drug code Schedule [FR Doc. 2024–09811 Filed 5–3–24; 8:45 am] Cocaine ........................ Methadone .................... 9041 9250 II II I Marsha Ikner, Acting Deputy Assistant Administrator. Drug Enforcement Administration [FR Doc. 2024–09785 Filed 5–3–24; 8:45 am] BILLING CODE P ddrumheller on DSK120RN23PROD with NOTICES1 I DEPARTMENT OF JUSTICE [Docket No. 1324] Importer of Controlled Substances Application: AndersonBrecon dba PCI Pharma Services; Correction Drug Enforcement Administration, Justice. ACTION: Notice of correction. AGENCY: VerDate Sep<11>2014 18:02 May 03, 2024 Jkt 262001 PO 00000 Frm 00101 II II II II II II II II II II II II II II II II II II II II II II II II II II II II DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1357] Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Correction Marsha Ikner, Acting Deputy Assistant Administrator. BILLING CODE 4410–09–P 9193 9220 9226 9230 9232 9233 9234 9250 9254 9273 9300 9330 9333 9600 9610 9620 9630 9639 9640 9652 9668 9737 9739 9740 9743 9780 9800 9801 Schedule Fmt 4703 Sfmt 4703 Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 5, 2024. Such persons may also file a written request for a hearing on the application on or before July 5, 2024. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for SUMMARY: E:\FR\FM\06MYN1.SGM 06MYN1

Agencies

[Federal Register Volume 89, Number 88 (Monday, May 6, 2024)]
[Notices]
[Pages 37257-37260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09811]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1361]


Importer of Controlled Substances Application: NSI Lab Solutions, 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: NSI Lab Solutions, Inc. has applied to be registered as an 
importer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
June 5, 2024. Such persons may also file a written request for a 
hearing on the application on or before June 5, 2024.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment. All 
requests for a hearing must be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152. All requests for a hearing should also be 
sent to: Drug Enforcement Administration, Attn: Administrator, 8701 
Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on March 22, 2024, NSI Lab Solutions, Inc., 7212 ACC 
Boulevard, Raleigh, North Carolina 27617, applied to be registered as 
an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)...         1233  I
Cathinone............................         1235  I
Methcathinone........................         1237  I
4-Fluoro-N-methylcathinone (4-FMC)...         1238  I
Pentedrone ([alpha]-                          1246  I
 methylaminovalerophenone).
Mephedrone (4-Methyl-N-                       1248  I
 methylcathinone).
4-Methyl-N-ethylcathinone (4-MEC)....         1249  I
Naphyrone............................         1258  I
3-methylmethcathinone (2-                     1259  I
 (methylamino)-1-(3-
 methylphenyl)propan-1-one).
N-Ethylamphetamine...................         1475  I
Methiopropamine (N-methyl-1-(thiophen-        1478  I
 2-yl)propan-2- amine).
N,N-Dimethylamphetamine..............         1480  I
Fenethylline.........................         1503  I
Aminorex.............................         1585  I
4-Methylaminorex (cis isomer)........         1590  I
4,4'-Dimethylaminorex (4,4'-DMAR; 4,5-        1595  I
 dihydro-4- methyl-5-(4-methylphenyl)-
 2-oxazolamine; 4-methyl-5- (4-
 methylphenyl)-4,5-dihydro-1,3-oxazol-
 2-amine).

[[Page 37258]]

 
Gamma Hydroxybutyric Acid............         2010  I
Methaqualone.........................         2565  I
Etizolam (4-(2-chlorophenyl)-2-ethyl-         2780  I
 9-methyl-6H-thieno[3,2-
 f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.
Flualprazolam (8-chloro-6-(2-                 2785  I
 fluorophenyl)-1-methyl-4H-
 benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine).
Clonazolam (6-(2-chlorophenyl)-1-             2786  I
 methyl-8-nitro-4H-
 benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.
Flubromazolam (8-bromo-6-(2-                  2788  I
 fluorophenyl)-1-methyl-4H-
 benzo[f][1,2,4]triazolo[4,3-
 a][1,4]diazepine.
Diclazepam (7-chloro-5-(2-chloro-5-(2-        2789  I
 chlorophenyl)-1- methyl-1,3-dihydro-
 2H-benzo[e][1,4]diazepin-2-one.
JWH-250 (1-Pentyl-3-(2-                       6250  I
 methoxyphenylacetyl) indole).
SR-18 (Also known as RCS-8) (1-               7008  I
 Cyclohexylethyl-3-(2-
 methoxyphenylacetyl) indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-        7010  I
 1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
 1H-indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 ([1-(5-             7011  I
 Fluoro-pentyl)1H-indol-3-yl]
 (2,2,3,3-
 tetramethylcyclopropyl)methanone).
AB-FUBINACA (N-(1-amino-3-methyl-1-           7012  I
 oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
 indazole-3-carboxamide).
(1-(4-Fluorobenzyl)-1H-indol-3-               7014  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone.
JWH-019 (1-Hexyl-3-(1-naphthoyl)              7019  I
 indole).
MDMB-FUBINACA (Methyl 2-(1-(4-                7020  I
 fluorobenzyl)-1H-indazole-3-
 carboxamido)-3,3-dimethylbutanoate).
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA           7021  I
 (2-(1-(4-fluorobenzyl)-1Hindazole-3-
 carboxamido)-3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-......         7023  I
1-oxobutan-2-yl)-1-pentyl-1H-indazole-
 )3-carboxamide.
THJ-2201 ([1-(5-fluoropentyl)-1H-             7024  I
 indazol-3-.
yl](naphthalen-1-yl)methanone).......
5F-AB-PINACA (N-(1-amino-3methyl-1-           7025  I
 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-
 indazole-3-carboxamide).
ADB-BUTINACA (N-(1-amino-3,3-dimethyl-        7027  I
 1-oxobutan2-yl)-1-butyl-1H-indazole-
 3-carb.
AB-CHMINACA (N-(1-amino-3-methyl-1-..         7031  I
oxobutan-2-yl)-1-(cyclohexylmethyl)-.
1H-indazole-3-carboxamide)...........
MAB-CHMINACA (N-(1-amino-3,3dimethyl-         7032  I
 1-oxobutan-2-yl)-1-
 (cyclohexylmethyl)-1H-indazole-3-
 carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-         7033  I
 1H-indazole-3-carboxamido)-3-
 methylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-        7035  I
 oxobutan-2-yl)-1-pentyl-1H-indazole-
 3-carboxamide).
Methyl 2-(1-(5-fluoropentyl)-1H-              7041  I
 indole-3-carboxamido)- 3,3-
 dimethylbutanoate.
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-          7042  I
 (1-(cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3,3-dimethylbutanoate).
4F-MDMB-BINACA (4F-MDMB-BUTINACA or           7043  I
 methyl 2- (1-(4-fluorobutyl)-1H-
 indazole-3-carboxamido)-3,3-
 dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-          7044  I
 (cyclohexylmethyl)-1H-indole-3-
 carboxamido)-3-methylbutanoate).
APINACA and AKB48 (N-(1-Adamantyl)-1-         7048  I
 pentyl-1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-                    7081  I
 methoxynaphthoyl) indole).
MDMB-4en-PINACA (methyl 3,3-dimethyl-         7090  I
 2-(1-(pent-4- en-1-yl)-1H-indazole-3-
 carboxamido)butanoate).
SR-19 (Also known as RCS-4) (1-Pentyl-        7104  I
 3-[(4-methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-             7118  I
 Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-              7122  I
 naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3-                  7144  I
 yl)(2,2,3,3-
 tetramethylcyclopropyl)methanone).
JWH-073 (1-Butyl-3-(1-                        7173  I
 naphthoyl)indole).
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-        7200  I
 (1-naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-              7201  I
 naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2-                       7203  I
 chlorophenylacetyl) indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-        7221  I
 fluoropentyl)-1H-indole-3-
 carboxylate).
PB-22 (Quinolin-8-yl 1-pentyl-1H-             7222  I
 indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-                 7225  I
 fluoropentyl)-1H-indole-3-
 carboxylate).
Alpha-ethyltryptamine................         7249  I
Ibogaine.............................         7260  I
Lysergic acid diethylamide...........         7315  I
Marihuana extract....................         7350  I
Marihuana............................         7360  I
Tetrahydrocannabinols................         7370  I
Mescaline............................         7381  I
JWH-398 (1-Pentyl-3-(4-chloro-1-              7398  I
 naphthoyl) indole).
3,4-Methylenedioxyamphetamine........         7400  I
3,4-Methylenedioxymethamphetamine....         7405  I
Alpha-methyltryptamine...............         7432  I
Bufotenine...........................         7433  I
Diethyltryptamine....................         7434  I
Dimethyltryptamine...................         7435  I
Psilocybin...........................         7437  I
Psilocyn.............................         7438  I
4-chloro-alpha-                               7443  I
 pyrrolidinovalerophenone (4-chloro-a-
 PVP).
N-Benzylpiperazine...................         7493  I
2C-I (2-(4-iodo-2,5-dimethoxyphenyl)          7518  I
 ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-               7521  I
 phenyl) ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-                 7524  I
 propylphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)         7535  I
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-        7537  I
 methoxybenzyl) ethanamine (25C-
 NBOMe).
Methylone (3,4-Methylenedioxy-N-              7540  I
 methylcathinone).
Butylone.............................         7541  I
Pentylone............................         7542  I

[[Page 37259]]

 
N-Ethylpentylone, ephylone (1-(1,3-           7543  I
 benzodioxol-5-yl)-2-(ethylamino)-
 pentan-1-one).
[alpha]-PVP (alpha-                           7545  I
 pyrrolidinopentiophenone).
[alpha]-PBP (alpha-                           7546  I
 pyrrolidinobutiophenone).
Ethylone.............................         7547  ....................
PV8, alpha-Pyrrolidinoheptaphenone...         7548  I
Eutylone.............................         7549  I
[alpha]-PiHP (4-methyl-1-phenyl-2-            7551  I
 (pyrrolidin-1-yl)pentan-1- one).
AM-694 (1-(5-Fluoropentyl)-3-(2-              7694  I
 iodobenzoyl) indole).
Acetyldihydrocodeine.................         9051  I
Codeine-N-oxide......................         9053  I
Desomorphine.........................         9055  I
Brorphine (1-(1-(1-(4-                        9098  I
 bromophenyl)ethyl)piperidin-4-yl)-
 1,3-dihydro-2H-benzo[d]imidazol-2-
 one).
Heroin...............................         9200  I
Morphine-N-oxide.....................         9307  I
Myrophine............................         9308  I
Nicomorphine.........................         9312  I
Normorphine..........................         9313  I
Pholcodine...........................         9314  I
Thebacon.............................         9315  I
U-47700 (3,4-dichloro-N-[2-                   9547  I
 (dimethylamino)cyclohexyl]-N-
 methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1-                  9551  I
 dimethylamino)cyclohexylmethyl]benza
 mide)).
MT-45 (1-cyclohexyl-4-(1,2-                   9560  I
 diphenylethyl)piperazine)).
Isotonitazene (N,N-diethyl-2-(2-(4            9614  I
 isopropoxybenzyl)-5- nitro-1H-
 benzimidazol-1-yl)ethan-1-amine).
Dimethylthiambutene..................         9619  I
Dipipanone...........................         9622  I
Etonitazene..........................         9624  I
Ketobemidone.........................         9628  I
Tilidine.............................         9750  I
Butonitazene (2-(2-(4-butoxybenzyl)-5-        9751  I
 nitro-1Hbenzimidazol-1-yl)-N,N-
 diethylethan-1.
Flunitazene (N,N-diethyl-2-(2-(4-             9756  I
 fluorobenzyl)-5-nitro1H-benzimidazol-
 1-yl)ethan-1-amine).
Metonitazene (N,N-diethyl-2-(2-(4-            9757  I
 methoxybenzyl)-5- nitro-1H-
 benzimidazol-1-yl)ethan-1-amine).
N-pyrrolidino etonitazene;                    9758  I
 etonitazepyne (2-(4-ethoxybenzyl)-5-
 nitro-1-(2- (pyrrolidin-1-yl)ethyl)-
 1H-benzimidazole).
Metodesnitazene (N,N-diethyl-2-(2-(4-         9759  I
 methoxybenzyl)- 1H-benzimidazol-1-
 yl)ethan-1-amine).
Metodesnitazene (N,N-diethyl-2-(2-(4-         9764  I
 methoxybenzyl)- 1H-benzimidazol-1-
 yl)ethan-1-amine).
Etodesnitazene; etazene (2-(2-(4-             9765  I
 ethoxybenzyl)-1Hbenzimidazol-1-yl)-
 N,N-diethyleth.
Acryl fentanyl (N-(1-                         9811  I
 phenethylpiperidin-4-yl)-N-
 phenylacrylamide).
Para-Fluorofentanyl..................         9812  I
3-Methylfentanyl.....................         9813  I
Alpha-Methylfentanyl.................         9814  I
Acetyl Fentanyl (N-(1-                        9821  I
 phenethylpiperidin-4-yl)-N-
 phenylacetamide).
Butyryl Fentanyl.....................         9822  I
Para-fluorobutyryl fentanyl..........         9823  I
4-Fluoroisobutyryl fentanyl (N-(4-            9824  I
 fluorophenyl)-N-(1-
 phenethylpiperidin-4-
 yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-          9825  I
 yl)-N-phenylacetamide.
Para-chloroisobutyryl fentanyl.......         9826  I
Isobutyryl fentanyl..................         9827  I
Furanyl fentanyl (N-(1-                       9834  I
 phenethylpiperidin-4-yl)-N-
 phenylfuran-2-carboxamide).
Thiofentanyl.........................         9835  I
Beta-hydroxythiofentanyl.............         9836  I
Ocfentanil...........................         9838  I
Valeryl fentanyl.....................         9840  I
Phenyl fentanyl (N-(1-                        9841  I
 phenethylpiperidin-4-yl)-
 Nphenylbenzamide; also known as
 benzoyl fentanyl).
beta'-Phenyl fentanyl (N-(1-                  9842  I
 phenethylpiperidin-4-yl)-N,3-
 diphenylpropanamide; also known as
 [beta]'-phenyl fentanyl; 3-
 phenylpropanoyl fentanyl).
N-(1-phenethylpiperidin-4-yl)-N-              9843  I
 phenyltetrahydrofuran-2-carboxamide).
Crotonyl fentanyl ((E)-N-(1-                  9844  I
 phenethylpiperidin-4-yl)-Nphenylbut-
 2-enam.
Cyclopropyl Fentanyl.................         9845  I
Cyclopentyl fentanyl.................         9847  I
Fentanyl related-compounds as defined         9850  I
 in 21 CFR 1308.11(h).
2'-Fluoro ortho-fluorofentanyl (N-(1-         9855  I
 (2- fluorophenethyl)piperidin-4-yl)-
 N-(2- fluorophenyl)propionamide;
 also known as 2'-fluoro 2-
 fluorofentanyl).
Amphetamine..........................         1100  II
Methamphetamine......................         1105  II
ANPP (4-Anilino-N-phenethyl-4-                8333  II
 piperidine).
Norfentanyl (N-phenyl-N-(piperidin-4-         8366  II
 yl)propionamide).
1-Piperidinocyclohexanecarbonitrile..         8603  II
Cocaine..............................         9041  II
Codeine..............................         9050  II
Dihydrocodeine.......................         9120  II
Oxycodone............................         9143  II
Hydromorphone........................         9150  II
Diphenoxylate........................         9170  II
Ecgonine.............................         9180  II
Ethylmorphine........................         9190  II

[[Page 37260]]

 
Hydrocodone..........................         9193  II
Levorphanol..........................         9220  II
Isomethadone.........................         9226  II
Meperidine...........................         9230  II
Meperidine-intermediate-A............         9232  II
Meperidine intermediate-B............         9233  II
Meperidine intermediate-C............         9234  II
Methadone............................         9250  II
Methadone intermediate...............         9254  II
Dextropropoxyphene, bulk (non-dosage          9273  II
 forms).
Morphine.............................         9300  II
Oripavine............................         9330  II
Thebaine.............................         9333  II
Opium, raw...........................         9600  II
Opium extracts.......................         9610  II
Opium fluid extract..................         9620  II
Opium tincture.......................         9630  II
Opium, powdered......................         9639  II
Opium, granulated....................         9640  II
Oxymorphone..........................         9652  II
Noroxymorphone.......................         9668  II
Alfentanil...........................         9737  II
Remifentanil.........................         9739  II
Sufentanil...........................         9740  II
Carfentanil..........................         9743  II
Tapentadol...........................         9780  II
Bezitramide..........................         9800  II
Fentanyl.............................         9801  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis. In reference 
to drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols) the 
company plans to import a synthetic cannabidiol and a synthetic 
tetrahydrocannabinol. No other activities for these drug codes are 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-09811 Filed 5-3-24; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.